Berkeley, United States
MicroByre, a cutting-edge player in the Biotechnology and Clean Energy sectors, was founded in 2017 and is headquartered in the United States. The company stands out with its unique approach: domesticating and genetically engineering non-cultivable bacteria to replace petrochemicals with renewable biomass.
Unlike traditional synthetic biology, MicroByre focuses on integrating naturally diverse prokaryotes in their processes, moving away from common organisms like Escherichia coli. Their slogan, "Micro.Bio.Tech.", encapsulates a mission: transforming bacteria into cooperative agents for sustainability.
Attracting significant financial backing, MicroByre secured a $14.71M Series A investment on 24 May 2022, supported by prominent names such as The House Fund and Lowercarbon Capital. This investment underscores strong confidence from investors like Azolla Ventures and Grantham Foundation in MicroByre's innovative potential and future impact.
